FRM
AMED

Fox Run Management’s Amedisys AMED Stock Holding History

Fox Run Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,513
Closed -$630K – 601
2022
Q3 		$630K Buy
+6,513
New +$777K 0.25% 105
2022
Q2 		– Sell
-3,305
Closed -$569K – 509
2022
Q1 		$569K Buy
+3,305
New +$494K 0.32% 68
2018
Q3 		– Sell
-2,506
Closed -$214K – 558
2018
Q2 		$214K Sell
2,506
-8,050
-76% -$591K 0.07% 562
2018
Q1 		$637K Buy
10,556
+5,456
+107% +$311K 0.15% 233
2017
Q4 		$269K Buy
+5,100
New +$269K 0.08% 491

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Fox Run Management's AMED Position: Q4 2022 in Review

Fox Run Management sold out of Amedisys (AMED) in Q4 2022, closing a stake of 6,513 shares — an estimated $630K sold.

Fox Run Management first reported a position in AMED in Q4 2017 and held it in 5 quarters. The position peaked at $637K in Q1 2018. 277 funds tracked by Wall St. Rank hold AMED as of Q4 2022.

  • Fox Run Management reported no remaining Amedisys position as of Q4 2022 after selling out during the quarter.
  • Fox Run Management sold 6,513 Amedisys shares in Q4 2022, an estimated $630K.
  • Fox Run Management first reported a position in Amedisys in Q4 2017 and held it in 5 quarters.
  • Fox Run Management's Amedisys position peaked at $637K in Q1 2018.
  • 277 funds tracked by Wall St. Rank held Amedisys as of Q4 2022.

Based on Fox Run Management's 13F filing for Q4 2022, filed 7 Feb 2023.